Legislation roundup: Pharma patents, AI medical software and patent pledges

An early resolution mechanism is in place for pharmaceutical patent disputes. Artificial intelligence medical software products are defined. Rules for registration of patent pledges are revised.

2 minute readJuly 23, 2021 at 05:11 AM

Susan Mok

Healthcare

National Medical Products Administration and China National Intellectual Property Administration, Implementing Measures for the Mechanism for the Early Resolution of Pharmaceutical Patent Disputes (Trial Implementation)

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)